The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer

Eur J Intern Med. 2022 May:99:121-123. doi: 10.1016/j.ejim.2022.01.028. Epub 2022 Jan 20.

Authors

Andreana Foresta¹, Pierluca Colacioppo², Marta Baviera², Luisa Ojeda-Fernandez², Claudio Cimminiello³

Affiliations

¹ Laboratory of Cardiovascular Prevention, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. Electronic address: andreana.foresta@marionegri.it.
² Laboratory of Cardiovascular Prevention, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
³ Arianna Foundation on Anticoagulation, Via Paolo Fabbri 1/3, 40138, Bologna, Italy.

PMID: 35067414
DOI: 10.1016/j.ejim.2022.01.028

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / therapeutic use
Humans
Neoplasms* / complications
Neoplasms* / drug therapy
Thromboembolism* / drug therapy
Warfarin

Substances

Anticoagulants
Warfarin